594 related articles for article (PubMed ID: 22923663)
21. The hedgehog system machinery controls transforming growth factor-β-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis.
Cigna N; Farrokhi Moshai E; Brayer S; Marchal-Somme J; Wémeau-Stervinou L; Fabre A; Mal H; Lesèche G; Dehoux M; Soler P; Crestani B; Mailleux AA
Am J Pathol; 2012 Dec; 181(6):2126-37. PubMed ID: 23031257
[TBL] [Abstract][Full Text] [Related]
22. Expression of WNT5A in Idiopathic Pulmonary Fibrosis and Its Control by TGF-β and WNT7B in Human Lung Fibroblasts.
Newman DR; Sills WS; Hanrahan K; Ziegler A; Tidd KM; Cook E; Sannes PL
J Histochem Cytochem; 2016 Feb; 64(2):99-111. PubMed ID: 26538547
[TBL] [Abstract][Full Text] [Related]
23. Eliglustat exerts anti-fibrotic effects by activating SREBP2 in TGF-β1-treated myofibroblasts derived from patients with idiopathic pulmonary fibrosis.
Kurumiya E; Iwata M; Kasuya Y; Tatsumi K; Honda T; Murayama T; Nakamura H
Eur J Pharmacol; 2024 Mar; 966():176366. PubMed ID: 38296153
[TBL] [Abstract][Full Text] [Related]
24. Nuclear factor erythroid 2-related factor 2 nuclear translocation induces myofibroblastic dedifferentiation in idiopathic pulmonary fibrosis.
Artaud-Macari E; Goven D; Brayer S; Hamimi A; Besnard V; Marchal-Somme J; Ali ZE; Crestani B; Kerdine-Römer S; Boutten A; Bonay M
Antioxid Redox Signal; 2013 Jan; 18(1):66-79. PubMed ID: 22703534
[TBL] [Abstract][Full Text] [Related]
25. The Long Noncoding RNA DNM3OS Is a Reservoir of FibromiRs with Major Functions in Lung Fibroblast Response to TGF-β and Pulmonary Fibrosis.
Savary G; Dewaeles E; Diazzi S; Buscot M; Nottet N; Fassy J; Courcot E; Henaoui IS; Lemaire J; Martis N; Van der Hauwaert C; Pons N; Magnone V; Leroy S; Hofman V; Plantier L; Lebrigand K; Paquet A; Lino Cardenas CL; Vassaux G; Hofman P; Günther A; Crestani B; Wallaert B; Rezzonico R; Brousseau T; Glowacki F; Bellusci S; Perrais M; Broly F; Barbry P; Marquette CH; Cauffiez C; Mari B; Pottier N
Am J Respir Crit Care Med; 2019 Jul; 200(2):184-198. PubMed ID: 30964696
[No Abstract] [Full Text] [Related]
26. LncRNA GAS5 suppresses TGF-β1-induced transformation of pulmonary pericytes into myofibroblasts by recruiting KDM5B and promoting H3K4me2/3 demethylation of the PDGFRα/β promoter.
Wang Y; Chen D; Xie H; Zhou S; Jia M; He X; Guo F; Lai Y; Tang XX
Mol Med; 2023 Mar; 29(1):32. PubMed ID: 36918759
[TBL] [Abstract][Full Text] [Related]
27. Novel differences in gene expression and functional capabilities of myofibroblast populations in idiopathic pulmonary fibrosis.
Walsh SM; Worrell JC; Fabre A; Hinz B; Kane R; Keane MP
Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L697-L710. PubMed ID: 30091381
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of RUNX1 blocks the differentiation of lung fibroblasts to myofibroblasts.
Dubey S; Dubey PK; Umeshappa CS; Ghebre YT; Krishnamurthy P
J Cell Physiol; 2022 Apr; 237(4):2169-2182. PubMed ID: 35048404
[TBL] [Abstract][Full Text] [Related]
29. Lactate, a novel trigger of transforming growth factor-β activation in idiopathic pulmonary fibrosis.
Tuder RM; Lara AR; Thannickal VJ
Am J Respir Crit Care Med; 2012 Oct; 186(8):701-3. PubMed ID: 23071184
[No Abstract] [Full Text] [Related]
30. Targeting MAP3K19 prevents human lung myofibroblast activation both in vitro and in a humanized SCID model of idiopathic pulmonary fibrosis.
Jones IC; Espindola MS; Narayanan R; Coelho AL; Habiel DM; Boehme SA; Ly TW; Bacon KB; Hogaboam CM
Sci Rep; 2019 Dec; 9(1):19796. PubMed ID: 31875033
[TBL] [Abstract][Full Text] [Related]
31. Increased fibroblast telomerase expression precedes myofibroblast α-smooth muscle actin expression in idiopathic pulmonary fibrosis.
Waisberg DR; Parra ER; Barbas-Filho JV; Fernezlian S; Capelozzi VL
Clinics (Sao Paulo); 2012 Sep; 67(9):1039-46. PubMed ID: 23018301
[TBL] [Abstract][Full Text] [Related]
32. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
[TBL] [Abstract][Full Text] [Related]
33. HuR drives lung fibroblast differentiation but not metabolic reprogramming in response to TGF-β and hypoxia.
Trivlidis J; Aloufi N; Al-Habeeb F; Nair P; Azuelos I; Eidelman DH; Baglole CJ
Respir Res; 2021 Dec; 22(1):323. PubMed ID: 34963461
[TBL] [Abstract][Full Text] [Related]
34. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568
[TBL] [Abstract][Full Text] [Related]
35. Bromodomain and Extraterminal (BET) Protein Inhibition Restores Redox Balance and Inhibits Myofibroblast Activation.
Stock CJW; Michaeloudes C; Leoni P; Durham AL; Mumby S; Wells AU; Chung KF; Adcock IM; Renzoni EA; Lindahl GE
Biomed Res Int; 2019; 2019():1484736. PubMed ID: 31119153
[TBL] [Abstract][Full Text] [Related]
36. Glycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis.
Xie N; Tan Z; Banerjee S; Cui H; Ge J; Liu RM; Bernard K; Thannickal VJ; Liu G
Am J Respir Crit Care Med; 2015 Dec; 192(12):1462-74. PubMed ID: 26284610
[TBL] [Abstract][Full Text] [Related]
37. LTBP2 is secreted from lung myofibroblasts and is a potential biomarker for idiopathic pulmonary fibrosis.
Enomoto Y; Matsushima S; Shibata K; Aoshima Y; Yagi H; Meguro S; Kawasaki H; Kosugi I; Fujisawa T; Enomoto N; Inui N; Nakamura Y; Suda T; Iwashita T
Clin Sci (Lond); 2018 Jul; 132(14):1565-1580. PubMed ID: 30006483
[TBL] [Abstract][Full Text] [Related]
38. Lactate levels in airways of patients with cystic fibrosis and idiopathic pulmonary fibrosis.
Worlitzsch D; Meyer KC; Döring G
Am J Respir Crit Care Med; 2013 Jul; 188(1):111. PubMed ID: 23815725
[No Abstract] [Full Text] [Related]
39. Reply: from idiopathic pulmonary fibrosis to cystic fibrosis: got lactate?
Kottmann R; Phipps R; Sime P
Am J Respir Crit Care Med; 2013 Jul; 188(1):111-2. PubMed ID: 23815724
[No Abstract] [Full Text] [Related]
40. Dysfunctional lactate metabolism in human alveolar type II cells from idiopathic pulmonary fibrosis lung explant tissue.
Newton DA; Lottes RG; Ryan RM; Spyropoulos DD; Baatz JE
Respir Res; 2021 Oct; 22(1):278. PubMed ID: 34711218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
